These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 36040402

  • 1. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
    Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M, Martin P, Carrion AF.
    Clin Liver Dis; 2019 May 01; 23(2):191-208. PubMed ID: 30947871
    [Abstract] [Full Text] [Related]

  • 5. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI, Kang SB.
    Korean J Gastroenterol; 2019 May 25; 73(5):248-259. PubMed ID: 31132831
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
    Silva J, Brito BS, Silva INN, Nóbrega VG, da Silva MCSM, Gomes HDN, Fortes FM, Pimentel AM, Mota J, Almeida N, Surlo VC, Lyra A, Rocha R, Santana GO.
    Biomed Res Int; 2019 May 25; 2019():7604939. PubMed ID: 30834274
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatobiliary associations with inflammatory bowel disease.
    Knight C, Murray KF.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 25; 3(6):681-91. PubMed ID: 19929587
    [Abstract] [Full Text] [Related]

  • 12. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM, Kumar S.
    Dig Dis Sci; 2015 Oct 25; 60(10):2873-80. PubMed ID: 25999245
    [Abstract] [Full Text] [Related]

  • 13. Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Nayagam JS, Mandour MO, Taylor A, Heneghan MA, Dubois PC, Hayee B, Lee HM, Vadamalayan B, Samyn M, Joshi D, Kent AJ.
    Clin Res Hepatol Gastroenterol; 2022 Oct 25; 46(7):101980. PubMed ID: 35728760
    [Abstract] [Full Text] [Related]

  • 14. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M.
    Acta Med Croatica; 2013 Apr 25; 67(2):195-201. PubMed ID: 24471303
    [Abstract] [Full Text] [Related]

  • 15. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I, Hayee B, Pavlidis P, Kvasnovsky C, Scalori A, Sisson G, Charlesworth A, Shaikh H, Bjornsson E, Heneghan MA.
    EBioMedicine; 2015 Oct 25; 2(10):1523-7. PubMed ID: 26629548
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Managing abnormal liver tests in children with inflammatory bowel disease.
    van Rheenen PF.
    Curr Opin Pediatr; 2021 Oct 01; 33(5):521-529. PubMed ID: 34261897
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.
    J Can Assoc Gastroenterol; 2019 Feb 01; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.